Ebola vaccine GOVX working on Ebola vaccine Zacks raise price target to $1.50 http://scr.zacks.com/News/Press-Releases/Press-Release-Details/2014/GOVX-GeoVax-Expands-Pipeline-by-Initiating-Ebola-Vaccine-Development-Program/default.aspx